GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...

Some band breakups are sad, and then there are the ones that feel like a friend moved away without saying goodbye. When ...